查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573854

體外受精（IVF）市場、機會、成長動力、產業趨勢分析與預測，2024-2032

In-vitro Fertilization (IVF) Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球體外受精市場估值為 202 億美元，預計 2024 年至 2032 年複合年成長率為 5.7%，主要由不孕率上升推動。根據世界衛生組織 (WHO) 報告，全球約有 1.86 億人患有不孕症。此外，多囊性卵巢症候群（PCOS）和子宮內膜異位症等疾病影響全球十分之一的女性，這也加劇了對體外受精的需求。

體外受精是一種透過在人體體外的實驗室環境中使卵子受精，然後將胚胎移植到女性子宮中來幫助受孕的醫療程序。作為輔助生殖技術 (ART) 的一種流行且有效的形式，體外受精可解決各種不孕症挑戰，包括排卵障礙、輸卵管受損和男性不孕症。

不孕不育病例的激增極大地推動了市場。例如，世界衛生組織的資料顯示，全球有六分之一的人面臨不孕症，凸顯了對生育照護的迫切需求。技術進步顯著提高了體外受精的成功率。例如，IVF 的成功率已從 1980 年代的約 10% 飆升至 2023 年每個週期的約 30-35%，具體取決於女性的年齡。延時成像技術使胚胎學家能夠密切監測胚胎髮育，提高選擇和植入成功率，從而提高體外受精的整體成功率。

整個產業分為產品、週期類型、程序、最終用途和地區。

按產品細分的市場包括設備、試劑和介質以及配件。設備領域到2023 年將引領市場，估值將達94 億美元，涵蓋多種領域，包括顯微鏡、成像系統、精子分析儀、卵子抽吸泵、顯微操作器、培養箱、氣體分析儀、低溫系統、雷射系統、精子分離系統、機櫃、防震台、見證系統和其他專用設備。

按週期類型細分顯示新鮮非捐贈者、冷凍非捐贈者、冷凍捐贈者和新鮮捐贈者。新的非捐贈者由於其卓越的成功率，在 2023 年佔據了 48.1% 的佔有率。在取出卵子後立即使用女性自己的卵子，新鮮的非捐贈週期有更高的成功率。這項優勢源自於卵子不會因冷凍和解凍而改變，而冷凍和解凍過程可能會損害其品質。

北美引領全球體外受精市場，2023 年收入為 62 億美元，預計到 2032 年將飆升至 98 億美元。及且有效的。延遲生育、生活方式選擇和健康狀況等因素導致了該地區的生育挑戰。由於許多夫婦因職業或個人原因而推遲生育，對生育治療（尤其是體外受精）的需求激增。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 不孕率上升
      • 技術進步和生育產業的擴張
      • 懷孕中位年齡增加
      • 有利的政府舉措
    • 產業陷阱與挑戰
      • 與生育手術相關的高成本
      • 社會和道德問題，尤其是發展中國家的社會和道德問題
  • 成長潛力分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 裝置
    • 顯微鏡
    • 影像系統
    • 精子分析儀系統
    • 抽卵泵
    • 顯微作業系統
    • 孵化器
    • 氣體分析儀
    • 冷凍系統
    • 雷射系統
    • 精子分離系統
    • 內閣
    • 防震台
    • 見證系統
    • 其他設備
  • 試劑和介質
    • 胚胎培養基
    • 冷凍保存介質
    • 精子處理介質
    • 卵子處理培養基
  • 配件

第 6 章：市場估計與預測：按週期類型，2021 年至 2032 年

  • 主要趨勢
  • 新的非捐贈者
  • 凍結非捐贈者
  • 冷凍捐贈者
  • 新的捐贈者

第 7 章：市場估計與預測：按程序，2021 - 2032

  • 主要趨勢
  • 傳統體外受精
  • IVF 胞漿內單一精子注射
  • 最小體外受精
  • 使用捐贈卵子進行體外受精
  • 其他手續

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 生育診所和試管受精中心
  • 醫院和外科中心
  • 科學研究機構
  • 冷凍庫

第 9 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Cook Medical
  • Esco Medical
  • FUJIFILM Irvine Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Genea BIOMEDX
  • Gynemed GmbH and Co. KG
  • Hamilton Thorne Ltd.
  • IVFtech ApS
  • Kitazato Corporation
  • Merck KGaA
  • Nidacon International AB
  • The Baker Company Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife Group
簡介目錄
Product Code: 11083

The Global In-Vitro Fertilization Market was valued at USD 20.2 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032, primarily driven by rising infertility rates. As reported by the World Health Organization (WHO), approximately 186 million individuals globally grapple with infertility. Furthermore, conditions like polycystic ovary syndrome (PCOS) and endometriosis, impacting 1 in 10 women worldwide, are fueling the heightened demand for IVF.

In-vitro fertilization is a medical procedure that aids conception by fertilizing an egg in a lab setting outside the human body and subsequently transferring the embryo into the woman's uterus. As a prevalent and effective form of Assisted Reproductive Technology (ART), IVF addresses various infertility challenges, including ovulation disorders, damaged fallopian tubes, and male infertility.

The surging infertility cases significantly propel the market. For instance, WHO data reveals that 1 in 6 individuals globally faces infertility, underscoring the pressing need for fertility care. Technological strides have markedly bolstered IVF success rates. For instance, IVF success rates have surged from roughly 10% in the 1980s to about 30-35% per cycle in 2023, contingent on the woman's age. Time-lapse imaging technology empowers embryologists to closely monitor embryo development, enhancing selection and implantation success rates, and thereby boosting overall IVF success.

The overall industry is classified into product, type of cycle, procedure, end-use, and region.

Market segmentation by product includes equipment, reagents and media, and accessories. The equipment segment, leading the market in 2023 with a valuation of USD 9.4 billion, encompasses a diverse range including microscopes, imaging systems, sperm analyzers, ovum aspiration pumps, micromanipulators, incubators, gas analyzers, cryosystems, laser systems, sperm separation systems, cabinets, anti-vibration tables, witness systems, and other specialized equipment.

Segmentation by cycle type reveals fresh non-donors, frozen non-donors, frozen donors, and fresh donors. The fresh non-donors led with a 48.1% share in 2023, attributed to their superior success rates. Utilizing a woman's own eggs immediately post-retrieval, fresh non-donor cycles boast higher success rates. This advantage stems from the eggs being unaltered by freezing and thawing, processes that could compromise their quality.

North America led the global in-vitro fertilization market with revenue of USD 6.2 billion in 2023, projected to soar to USD 9.8 billion by 2032. Renowned for its cutting-edge medical technology, North American fertility clinics leverage latest advancements in reproductive medicine for ensuring IVF remains both accessible and effective. Factors like delayed childbearing, lifestyle choices, and health conditions contribute to the region's fertility challenges. As many couples postpone parenthood for career or personal reasons, the appetite for fertility treatments, notably IVF, has surged.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing infertility rates
      • 3.2.1.2 Technological advancements and expansion of fertility industry
      • 3.2.1.3 Increasing median age of pregnancy
      • 3.2.1.4 Favorable government initiatives
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High costs associated with fertility procedures
      • 3.2.2.2 Social and ethical concerns especially in developing countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Equipment
    • 5.2.1 Microscope
    • 5.2.2 Imaging system
    • 5.2.3 Sperm analyzer system
    • 5.2.4 Ovum aspiration pump
    • 5.2.5 Micromanipulator system
    • 5.2.6 Incubator
    • 5.2.7 Gas analyzer
    • 5.2.8 Cryosystem
    • 5.2.9 Laser system
    • 5.2.10 Sperm separation system
    • 5.2.11 Cabinet
    • 5.2.12 Anti-vibration table
    • 5.2.13 Witness system
    • 5.2.14 Other equipment
  • 5.3 Reagents and media
    • 5.3.1 Embryo culture media
    • 5.3.2 Cryopreservation media
    • 5.3.3 Sperm processing media
    • 5.3.4 Ovum processing media
  • 5.4 Accessories

Chapter 6 Market Estimates and Forecast, By Type of Cycle, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Fresh non-donors
  • 6.3 Frozen non-donors
  • 6.4 Frozen donors
  • 6.5 Fresh donors

Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Conventional IVF
  • 7.3 IVF with intracytoplasmic sperm injections
  • 7.4 Minimal IVF
  • 7.5 IVF with donor eggs
  • 7.6 Other procedures

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Fertility clinics and IVF centers
  • 8.3 Hospitals and surgical centers
  • 8.4 Research institutes
  • 8.5 Cryobanks

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Cook Medical
  • 10.2 Esco Medical
  • 10.3 FUJIFILM Irvine Scientific, Inc.
  • 10.4 GE HealthCare Technologies, Inc.
  • 10.5 Genea BIOMEDX
  • 10.6 Gynemed GmbH and Co. KG
  • 10.7 Hamilton Thorne Ltd.
  • 10.8 IVFtech ApS
  • 10.9 Kitazato Corporation
  • 10.10 Merck KGaA
  • 10.11 Nidacon International AB
  • 10.12 The Baker Company Inc.
  • 10.13 The Cooper Companies Inc.
  • 10.14 Thermo Fisher Scientific Inc.
  • 10.15 Vitrolife Group